TRIM33 and Miyoshi myopathy: TRIM33 downregulation was identified as part of a 70-gene signature associated with high-risk MM [39], whereas in CMML DNA hypermethylation of the TRIM33 promoter region was observed in 35% of patients, leading to decreased expression [35].